Literature DB >> 33990118

CILIORETINAL ARTERIES INFLUENCE OPTIC NERVE HEAD, PERIPAPILLARY, AND MACULAR VESSEL DENSITIES IN HEALTHY EYES: An Optical Coherence Tomography Angiography Study.

Raphael Diener1, Martin D Leclaire1, Franziska Eckardt1, Jost L Lauermann1, Maged Alnawaiseh1,2, Nicole Eter1, Maximilian Treder1.   

Abstract

BACKGROUND/
PURPOSE: To analyze the influence of a cilioretinal artery (CRA) on macular and peripapillary vessel density in healthy eyes as measured using optical coherence tomography angiography.
METHODS: A total of 83 eyes of 83 patients were included in this study. Optical coherence tomography angiography was performed using the RTVue XR Avanti with AngioVue (Optovue Inc). The macula was imaged with a 3 × 3-mm scan, whereas for the optic nerve head a 4.5 × 4.5-mm scan was taken. Optical coherence tomography angiography images of the optic nerve head were screened for the presence of a CRA.
RESULTS: In 31 eyes, a CRA was detected (37.3%). The vessel density in eyes with a CRA was significantly lower within the optic nerve head (P = 0.005) but higher in the peripapillary capillary network (P < 0.001) and (whole en face) macular superficial capillary plexus (P = 0.025), when compared with eyes with no CRA.
CONCLUSION: Our findings reveal that in eyes with a CRA, the vessel density in the peripapillary and macular superficial capillary plexus is increased, whereas the optic nerve head perfusion (as indicated by vessel density in the inside disk region) is decreased. This has to be considered when analyzing quantitative optical coherence tomography angiography parameters in scientific and clinical applications.

Entities:  

Mesh:

Year:  2021        PMID: 33990118     DOI: 10.1097/IAE.0000000000003208

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  1 in total

1.  Commentary: Retinal and choroidal vascular changes in newly diagnosed celiac disease: An optical coherence tomography angiography study - - Are we going overboard?

Authors:  Alok Sen; Gaurav M Kohli
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.